CasNo.910463-68-2,Factory Supply 99.3% USP/EP/DMF CAS 910463-68-2 Sermaglutide Semaglutide,(910463-68-2) Suppliers

1 Gram	FOB Price:USD 300.0000 -350.0000

Min.Order :1 Gram
Purity: 99.3%
Payment Terms : L/C,T/T

Keywords

Ozempic Rybelsus Ozempic Semaglutide (H-7894.0001)

Quick Details

Appearance:white powder
Application: manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity. It also works by slowing the movement of food through the stomach and may decrease a
PackAge:1g/bag
ProductionCapacity:1|Kilogram|Week
Storage:-20℃
Transportation:-20℃

Superiority:

Hangzhou Jinlan Pharm-Drugs Technology Co. Ltd.(JL Pharm) is an advanced pharmaceutical corporation with a laboratory of 1200 square meters in Nanjing city, and cooperative GMP production plants in Beljing, Jiangsu, Zhejiang, Jiangxi, Chengdrand Shandong.We can provide both CDMO technology research and development services, and a ful range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to globapharmaceutical companies during which synthetic route research and development, process reearch and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.

Details:

Product Name:   Semaglutide

Synonyms:
Sermaglutide;Semaglutide impurity;
Sermaglutide USP/EP/BP;
semaglutide;
Sermaglutide CAS 910463 68 2;
Ozempic, Rybelsus;Ozempic;
Semaglutide (H-7894.0001)
CAS:   910463-68-2
MF:   C187H291N45O59
MW:   4113.57754
EINECS:   203-405-2
Product Categories:   GLP;PP;APIs;API;910463-68-2
Mol File:   910463-68-2.mol
Semaglutide Chemical Properties
storage temp.    Store at -20°C
solubility    DMSO:3mg/mL (0.73 mM)
InChIKey   DLSWIYLPEUIQAV-CCUURXOWSA-N
Uses   Semaglutide is used to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity. It also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss. There have been no published reports of hepatotoxicity attributed to semaglutide therapy.

Mechanism of action   Semaglutide is a glucagon-like peptide-1 receptor agonist. It increases the production of insulin, a hormone that lowers the blood sugar level. It also appears to enhance growth of β cells in the pancreas, which are the sites of insulin production. It also inhibits glucagon, which is a hormone that increases blood sugar. It additionally reduces food intake by lowering appetite and slows down digestion in the stomach. In this way it reduces body fat.

Amino acid analysis

Asp	0.9-1.1	0.9
Ser	2.1-3.9	2.6
Glu	4.5-5.5	5.1
Gly	3.6-4.4	4.0
His	0.9-1.1	1.0
Arg	1.8-2.2	2.1
Thr	1.8-2.2	2.0
Ala	2.7-3.3	3.0
Aib	0.7-1.3	1.1
Tyr	0.9-1.1	1.0
Val	1.8-2.2	2.2
Lys	0.9-1.1	1.0
Ile	0.9-1.1	1.0
Leu	1.8-2.2	2.1
Phe	1.8-2.2	2.1
Trp	Present	Present

Sodium ion	1.0%~3.0%		2.1%
Carbonate	≤0.50%		0.09%
Acetic acid	≤0.50%		N.D
Trifluoroacetic acid	≤0.25%		N.D.
Related Substance	G06-IM60	≤0.2%	0.08%
	G06-IM01	≤0.2%	0.07%
	G06-1M59	≤0.2%	0.06%
	G06-IM28	≤0.2%	0.08%
	G06-IM03	≤0.2%	0.07%
	Any other Unknown individual impurity	≤0.1%	N.D.
	Total Impurities	≤2.0%	0.29%
Residue solvents	Acetonitrile	≤410ppm	N.D.
	Triethylamine	≤5000ppm	17 ppm
	NN’-Diisopropylcarbodiimide	≤100ppm	N.D.
Polymer	≤0.5%		0.03%
Bacterial endotoxins	<10EU/mg		<10EU/mg
Microbial limit	Total aerobic microbial count	≤10²cfu/g	<10 cfu/g
	Total yeast and mold count	≤10²cfu/g	<10 cfu/g
	Escherichia coli	Absent	N.D.
Peptide content	≥80.0%		93.5%
Assay(on anhydrous and salt free substance basis)	95.0%-105.0%		99.3%